Post-IPO Equity - Vigil Neuroscience
Investment Firm
Overview
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Announced Date
Jun 27, 2024
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Vigil Neuroscience raised $40000000 on 2024-06-27 in Post-IPO Equity
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 08, 2020 |  Series A - Vigil Neuroscience | 4 | - | 50.0M |
| Aug 18, 2021 | Series B - Vigil Neuroscience | 13 | - | 90.0M |
| Jun 27, 2024 | Post-IPO Equity - Vigil Neuroscience | 1 | - | 40.0M |
Recent Activity
News
Jun 28, 2024
donews.com - 生物技术公司Vigil Neuroscience获得4000万美元战略投资
News
Jun 27, 2024
MarketScreener - Vigil Neuroscience Shares Soar on $40 Million Sanofi Investment
News
Jun 27, 2024
Vigil Neuroscience, Inc - Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi
News
Jun 27, 2024
Globe Newswire - Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi